U.S. Commercial Services Stock News

La-Z-Boy (LZB) recently introduced its AudioLuxe furniture line, integrating Klipsch audio systems into recliners and sofas. This product move has drawn attention to how this home furnishings stock is currently priced. See our latest analysis for La-Z-Boy. The AudioLuxe launch and the latest quarterly dividend affirmation arrive after an 11.2% 1 month share price return, but with year to date share price return and 1 year total shareholder return both still negative, momentum looks more like...

In the first quarter ended March 31, 2026, Ameris Bancorp reported net interest income of US$244.44 million and net income of US$110.49 million, alongside net charge-offs of US$11.35 million and continued share repurchases. Management coupled higher profitability with efficiency below 50% and buybacks that retired 5.33% of shares since 2019, sharpening the capital profile. Next, we’ll examine how Ameris Bancorp’s stronger year-over-year earnings and active share repurchases reshape the...

Atlas Energy Solutions recently advanced construction of its long-haul proppant conveyor and completed a US$390 million private offering of 0.50% Convertible Senior Notes due 2031 to support its logistics and growth plans. These initiatives highlight Atlas’s push to modernize sand delivery for hydraulic fracturing while raising fresh capital amid questions over expenses, cash burn, and long-term profitability. We’ll now examine how the ambitious Dune Express conveyor project and related...

In April 2026, Xerox Holdings reported first‑quarter 2026 revenue of US$1.85 billion, up from US$1.46 billion a year earlier, while its net loss widened to US$105 million and loss per share from continuing operations increased to US$0.84. A few days earlier, Xerox also launched its AI-powered “Xerox IT as a Service” platform built on ServiceNow, underscoring its push to evolve from legacy print hardware into a services-led, IT and automation provider for small and mid-sized businesses. Next,...

On 20 April 2026, Arcus Biosciences and Gilead Sciences discontinued the Phase 3 STAR-121 and Phase 2 EDGE-Lung studies in metastatic non-small cell lung cancer after an Independent Data Monitoring Committee deemed the domvanalimab plus zimberelimab and chemotherapy arm futile, while zimberelimab plus chemotherapy showed overall survival in line with pembrolizumab plus chemotherapy. Arcus also disclosed that Gilead will let certain option rights lapse in July 2026, narrowing access to...

ASA Gold and Precious Metals Limited recently renewed its authorization to repurchase up to 5% of its common shares through April 30, 2027, allowing opportunistic buybacks when the fund trades at a discount to net asset value. This move comes as trading models highlight weak near-term sentiment and stress-tested support levels, underscoring how capital management and technical signals intersect for this specialized precious-metals fund. With recent share price declines and a renewed buyback...

Exponent, Inc. reported past first-quarter 2026 results with sales of US$151.82 million, total revenue of US$166.3 million, and net income of US$29.57 million, alongside basic and diluted EPS of US$0.59 from continuing operations and a quarterly dividend of US$0.31 per share. The company paired this earnings strength with maintained high-single-digit revenue growth guidance, leadership changes, and an expanded share repurchase authorization, highlighting management’s focus on long-term...

First Industrial Realty Trust, Inc. recently reported first-quarter 2026 results showing higher sales of US$194.83 million and net income of US$143.10 million, and the board declared a US$0.5000 quarterly dividend payable on July 20, 2026 to shareholders of record on June 30, 2026. The company also issued full-year 2026 net income guidance of US$2.32 to US$2.42 per share, giving investors a clearer view of expected profitability alongside the confirmed dividend payout. We’ll now examine how...

Reinsurance Group of America, Incorporated recently announced it will redeem in full on June 15, 2026, all of its outstanding US$400 million 5.75% Fixed-to-Floating Rate Subordinated Debentures due 2056 at par plus accrued interest, after which interest on these securities will stop accruing. This move marks a meaningful capital structure adjustment, signaling a shift in how the company manages long-dated subordinated debt within its broader financing mix. We’ll now examine how this full...

Carlyle Group (CG) shares attracted fresh attention after the firm expanded its partnership with SEI, a move aimed at widening access to institutional-quality private market solutions for wealth and retirement investors. See our latest analysis for Carlyle Group. The strengthened SEI partnership has arrived at a time when Carlyle’s share price has shown a 6.21% 1 month share price return but remains lower over the year to date, while multi year total shareholder returns above 100% point to...

Bank of N.T. Butterfield & Son reported first-quarter 2026 results showing higher net interest income of US$93.28 million and net income of US$62.62 million, with earnings per share rising versus the prior year, while also affirming a quarterly dividend of US$0.50 per share and completing a 800,000-share buyback for US$42.40 million. Alongside these stronger earnings, the completed acquisition of Rollinson and Hunter Guernsey expands Butterfield’s private trust footprint, potentially...

Understanding the recent move in Resolute Holdings Management stock Resolute Holdings Management (RHLD) has drawn attention after a period of mixed share performance, including a 10.38% decline over the past month and a 31.01% decline over the past 3 months, prompting closer inspection from investors. See our latest analysis for Resolute Holdings Management. At a share price of $138.38, RHLD sits well below its recent 90 day share price return of a 31.01% decline, even as its 1 year total...

Recent trading in Gorman-Rupp (GRC) has drawn attention after the stock’s one-month return of 21.8% and three-month return of 35.1%, prompting investors to reassess the pump manufacturer’s current valuation and fundamentals. See our latest analysis for Gorman-Rupp. Zooming out beyond the recent surge, Gorman-Rupp’s 30-day share price return of 21.8% and year-to-date share price return of 58.2%, alongside a 1-year total shareholder return of 110.0%, indicate momentum backed by reinvested...

U.S. Bancorp (USB) is back in focus after recent share price moves, with the stock closing at $56.30. Investors are weighing that level against the bank’s earnings profile, dividends and perceived longer term value. See our latest analysis for U.S. Bancorp. Against a 41.5% 1 year total shareholder return and a 110.6% 3 year total shareholder return, the recent 6.3% 1 month share price return indicates momentum has been building again despite some softer 90 day share price performance. If U.S...

Why Urban Outfitters is on investors’ radar today Urban Outfitters (URBN) has attracted attention after recent share price swings, with the stock showing mixed performance over the past week, month and past 3 months. Investors are reassessing its valuation and recent financial progress. See our latest analysis for Urban Outfitters. At a share price of $69.01, Urban Outfitters has seen a 6.88% 1 month share price return, contrasted with an 8.40% share price decline year to date. Its 1 year...

Markets are wrestling with sticky inflation, higher energy costs and central banks that are firmly data dependent, which leaves a lot of investors sitting on the sidelines. That hesitation can create an opening for you. Our High-Quality Undiscovered Gems screener focuses on smaller companies with solid fundamentals that are not yet crowded with big institutional money. The goal is simple: help you look beyond the usual mega cap stories and find underfollowed names where company quality, not...

Why Exzeo Group is on investor watchlists Exzeo Group (XZO) has been drawing attention after recent trading swings, with the share price at US$16.40 and mixed short term returns. These include a 15.0% gain over the past month and a 22.0% decline over the past 3 months. See our latest analysis for Exzeo Group. Those swings sit within a wider pattern, with a 15.0% 1 month share price return contrasting with a 22.0% 3 month share price decline and a 27.9% year to date share price loss. This...

In the first quarter of 2026, ADT Inc. reported slightly higher year-on-year revenue of US$1,279 million and net income of US$168 million, completed a 35,000,000-share repurchase for US$230 million, reaffirmed expectations for approximately flat full-year revenue, and declared a quarterly dividend of US$0.055 per share. These results highlighted robust free cash flow, margin-driven earnings above analyst expectations, and increased investment in ADT+ and the new ADT Blue DIY offering,...

Mueller Industries reported past first-quarter 2026 results with sales of US$1,193.01 million and net income of US$239.02 million, alongside higher basic and diluted earnings per share from continuing operations than a year earlier. Over the same period, the company completed a long-running share repurchase program dating back to 2000, retiring 19,529,490 shares for a total of US$850.33 million, which materially reduced its share count. Next, we will examine how this combination of strong...

In April 2026, Nicolet Bankshares, Inc. reported first-quarter results showing net interest income of US$109.56 million but lower net income of US$15.2 million, alongside higher net loan charge-offs of US$833,000 compared with a year earlier. The company also continued returning capital to shareholders through its long-running buyback program and announced a higher quarterly dividend of US$0.36 per share payable on June 15, 2026. We’ll now examine how the combination of weaker earnings and a...

Pebblebrook Hotel Trust reported first-quarter 2026 results showing revenue of US$345.66 million and a net loss of US$19.27 million, both improved from a year earlier. The company paired these results with a wide full-year 2026 outlook ranging from a US$6.00 million net loss to a US$6.00 million net profit, underlining both progress and uncertainty. Next, we’ll examine how the improved first-quarter loss and raised full-year guidance shape Pebblebrook’s existing investment narrative. We've...

Recently, CG Oncology, Inc. was upgraded to a Zacks Rank #2 (Buy) following an upward trend in its earnings estimates, reflecting increased optimism about its earnings outlook. This shift in analyst sentiment highlights how changes in projected earnings can quickly reshape perceptions of a company’s underlying business strength. We’ll now examine how this analyst upgrade, driven by rising earnings estimates, influences CG Oncology’s broader investment narrative for investors. Outshine the...

Why Copart is on investors’ radar today Copart (CPRT) is drawing attention after a period in which the stock shows a 16.15% decline over the past 3 months and a 45.66% decline over the past year. This recent performance is prompting closer scrutiny of its underlying business. See our latest analysis for Copart. Despite a modest 0.6% 7 day share price return at around US$33.27, Copart’s recent 3 month share price return of negative 16.15% and 1 year total shareholder return of negative 45.66%...

D.R. Horton (DHI) is back in focus after its latest quarterly update, which combined softer year over year earnings, a trimmed yet still higher full year revenue outlook, and ongoing pressure from housing affordability. See our latest analysis for D.R. Horton. The share price has been under pressure in the short term, with a 1 day share price return of a 2.52% decline and a 7 day share price return of a 6.20% decline, even though the 1 year total shareholder return is 18.82%. This suggests...